General Information of DTT (ID: TTC24WT)

DTT Name C-C chemokine receptor type 1 (CCR1) DTT Info
Gene Name CCR1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMS-817399 DMT8L6P Rheumatoid arthritis FA20 Phase 2 [1]
CCX-354 DMSHV9C Autoimmune diabetes 5A10 Phase 2 [2]
AVE1701 DMJY35M Rheumatoid arthritis FA20 Phase 1 [3]
------------------------------------------------------------------------------------
3 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZD4818 DM3VFKM Chronic obstructive pulmonary disease CA22 Discontinued in Phase 2 [4]
MLN3897 DMRA3EZ Rheumatoid arthritis FA20 Discontinued in Phase 2 [3]
COSALANE DMO3486 N. A. N. A. Terminated [5]
------------------------------------------------------------------------------------
3 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
A-987306 DMU34BK Discovery agent N.A. Investigative [6]
BX 471 DM5CGXB Discovery agent N.A. Investigative [7]
Cosalane derivative DMSFXJ8 Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis. J Med Chem. 2014 Sep 25;57(18):7550-64.
2 Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Ann Rheum Dis. 2013 Mar;72(3):337-44.
3 Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
4 Clinical pipeline report, company report or official report of AstraZeneca (2009).
5 Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds. Bioorg Med Chem Lett. 2001 Jan 8;11(1):59-62.
6 cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain... J Med Chem. 2008 Nov 27;51(22):7094-8.
7 Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem. 2000 Jun 23;275(25):19000-8.